Morocco medicine price database

OKARUBICIN

DOXORUBICINE

Public price

90,00 MAD

Reimbursement base

90,00 MAD

Active substance

DOXORUBICINE

Reimbursable

What is this medicine?

An anthracycline topoisomerase inhibitor that exerts cytotoxic effects on malignant cells by inhibiting nucleotide replication and the action of DNA and RNA polymerases, and by forming DNA-cleavable complexes with topoisomerase II.

Verified summary

DOXORUBICINE, LYOPHILISAT POUR SOLUTION INJECTABLE, 10 MG, 1 BOITE 1 FLACON

Common uses

Treatment of acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin lymphoma, Non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms' tumor, metastatic neuroblastoma, metastatic soft tissue sarcoma, metastatic bone sarcomas, metastatic ovarian carcinoma, metastatic transitional cell bladder carcinoma, metastatic thyroid carcinoma, metastatic gastric carcinoma, metastatic bronchogenic carcinoma, and as a component of multi-agent adjuvant chemotherapy for women with axillary lymph node involvement following resection of primary breast cancer.

Class

anthracycline topoisomerase inhibitor

Availability note

Reimbursable

Hospital price

56,20 MAD

Strength

10 MG

Form

LYOPHILISAT POUR SOLUTION INJECTABLE

Presentation

1 BOITE 1 FLACON

Type

G

Therapeutic class

ANTINEOPLASIQUE CYTOTOXIQUE

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2017-12-18: 90,00 MAD

Available presentations and strengths

Medicines with the same active substance